Krystal Biotech buy Cantor Fitzgerald
Start price
20.02.25
/
50%
€178.75
Target price
20.02.26
€205.35
Performance (%)
13.68%
Price
16.12.25
€203.20
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald currently has a performance of 13.68%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.644% | 0.644% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
13.12.23
13.12.23
€166.84
13.12.24
13.12.24
47.38%
14.12.24
14.12.24
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24